Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Nanobiotix shares fell by 4.32% to €27.48 mid-session on Monday, after closing at €28.72. The decline is part of a broader dip, with the CAC 40 down b…
Nanobiotix drops 0.99% to €28.06 in late afternoon trading on Euronext Paris, amidst a 0.34% decline in the CAC 40. The oncological nanomedicine biote…
Nanobiotix stands out in Thursday's Paris trading session with a 5.48% increase to 28.50 euros. The French medtech company specializing in nanomedicin…
Nanobiotix significantly advanced this Wednesday, driven by a notable upward momentum over recent months. The stock of the French biotech specializing…
Nanobiotix announced on Monday the presentation of new preclinical data evaluating its nanoprimer platform combined with DNA immunotherapies delivered…
This Tuesday, Nanobiotix shows a significant increase of 5.46% to €27.80 in a generally well-oriented Parisian market. The French biotech company, spe…
Nanobiotix is down 2.03% this Monday mid-session, at 25.06 euros, in a declining Parisian market. The biotech specialized in nanomedicine, however, sh…
Nanobiotix is among the most dynamic stocks in the SBF 120 this Friday morning, with a gain of 4.28% at €26.78. The biotech specialized in nanomedicin…
Nanobiotix falls 2.47% mid-morning on Thursday, at 25.24 euros, in a declining Paris market. The stock, which has increased its value by more than eig…
Nanobiotix continues its upward trajectory this Wednesday, April 8, 2026, with shares trading at €26.76 mid-morning, up 4.45% from the previous day's …
